Federal regulators have recalled nearly 90,000 bottles of a children’s pain reliever due to reports of black specs and other contaminants, the Associated Press reported.
The Food and Drug Administration posted an online notice about the recall of Taro Pharmaceuticals’ Children’s Ibuprofen Oral Suspension.
The FDA notice states that the recall was launched earlier this month after customers reported “a gel-like mass and black particles in the product.”
The risk of serious injury or health consequences to consumers is “remote.”
The medication was manufactured in India by Strides Pharma Inc., which produces generic and over-the-counter medicines for firms in the U.S. Strides initiated the recall, according to the FDA notice.
